The Association of Urinary Sclerostin and Renal Magnesium Handling in Type 2 Diabetic Patients with Chronic Kidney Disease

被引:3
|
作者
Wu, Ching-Fang [1 ,2 ]
Liou, Hung-Hsiang [3 ,4 ]
Kuo, Chin-Chi [5 ,6 ]
Tsai, Ming-Hsien [7 ]
Chang, Min-Yu [1 ,4 ]
Lee, Yi-Che [1 ,8 ]
Lin, Tsun-Mei [9 ,10 ]
Hung, Shih-Yuan [1 ,4 ]
机构
[1] I Shou Univ, Coll Med, Sch Med, Kaohsiung, Taiwan
[2] E Da Canc Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan
[3] Hsin Jen Hosp, Dept Internal Med, Div Nephrol, New Taipei, Taiwan
[4] E Da Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan
[5] China Med Univ, China Med Univ Hosp, Big Data Ctr, Taichung, Taiwan
[6] China Med Univ Hosp, Dept Internal Med, Div Nephrol, Taichung, Taiwan
[7] Shin Kong Wu Ho Su Mem Hosp, Dept Internal Med, Div Nephrol, Taipei, Taiwan
[8] E Da Dachang Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan
[9] I Shou Univ, Dept Med Lab Sci, Kaohsiung, Taiwan
[10] E Da Hosp, Dept Med Res, Kaohsiung, Taiwan
关键词
Chronic kidney disease; Sclerostin; Fractional excretion of calcium; Fractional excretion of magnesium; Type 2 diabetes mellitus; METABOLISM; CALCIUM;
D O I
10.1159/000516844
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Introduction: Sclerostin could enhance renal excretion of calcium (Ca) and phosphate (P). The association between sclerostin and magnesium (Mg) has not yet discovered. In patients with type 2 diabetes mellitus (T2DM) or chronic kidney disease (CKD), higher serum sclerostin and altered renal excretion of Ca, P, and Mg were detected. Therefore, we tried to evaluate if there was any association between sclerostin and fractional excretion of Ca, P, and Mg (FeCa, FeP, and FeMg) in T2DM with CKD. Methods: In this prospective cohort study, 43 T2DM patients without CKD or with CKD stage 1-5 were enrolled. Values of parameters, including serum and urine sclerostin, were collected at baseline and 6 months later. For baseline data, the Mann-Whitney U test, chi(2) test, or Spearman's correlation were used. For multivariate repeated measurement analysis, generalized estimating equation (GEE) model was utilized. Results: Patients with lower estimated glomerular filtration rate had higher serum sclerostin, FeP, FeMg, and lower FeCa. By correlation analysis, serum sclerostin was negatively associated with FeCa (p = 0.02) and positively associated with FeP (p = 0.002). The urine sclerostin to creatinine ratio (Uscl/Ucre) was positively correlated with FeP (p = 0.007) and FeMg (p = 0.005). After multivariate analyses by GEE model, serum sclerostin was still inversely associated with FeCa, while Uscl/Ucre was significantly associated with FeMg. On the other hand, FeP lost its associations with serum sclerostin or Uscl/Ucre. Conclusion: In our study population of T2DM patients with or without CKD, the inverse correlation between serum sclerostin and FeCa could not be explained by the calciuric effect of sclerostin. In addition, a newly discovered positive association between urinary sclerostin and FeMg indicated a possible role of urinary sclerostin in regulating renal Mg handling especially over distal convoluted tubules.
引用
收藏
页码:514 / 522
页数:9
相关论文
共 50 条
  • [41] Urinary magnesium predicts risk of cardiovascular disease in Chronic Kidney Disease stage 1-4 patients
    Yuan, Qiongjing
    Xie, Yanyun
    Peng, Zhangzhe
    Wang, Jinwei
    Zhou, Qiaoling
    Xiao, Xiangcheng
    Wang, Wei
    Huang, Ling
    Tang, Wenbin
    Li, Xiaozhao
    Zhang, Luxia
    Wang, Fang
    Zhao, Ming-Hui
    Tao, Lijian
    He, Kevin
    Wanggou, Siyi
    Xu, Hui
    CLINICAL NUTRITION, 2021, 40 (04) : 2394 - 2400
  • [42] Association between the urinary sodium-to-potassium ratio and renal outcomes in patients with chronic kidney disease: a prospective cohort study
    Yuta Matsukuma
    Masaru Nakayama
    Susumu Tsuda
    Akiko Fukui
    Ryota Yoshitomi
    Kazuhiko Tsuruya
    Toshiaki Nakano
    Takanari Kitazono
    Hypertension Research, 2021, 44 : 1492 - 1504
  • [43] The association between the amount and timing of coffee consumption with chronic kidney disease in diabetic patients
    Tang, Yiwei
    Zhou, Qin
    Zhao, Ni
    Niu, Fengru
    Li, Shangying
    Zuo, Yingdong
    Huang, Jiaxin
    Wang, Zheng
    Han, Tianshu
    Wei, Wei
    FOOD & FUNCTION, 2024, 15 (20) : 10504 - 10515
  • [44] Association of Constipation with risk of end-stage renal disease in patients with chronic kidney disease
    Lu, Chung-Yen
    Chen, Yin-Cheng
    Lu, Yu-Wen
    Muo, Chih-Hsin
    Chang, Ray-E
    BMC NEPHROLOGY, 2019, 20 (01)
  • [45] Only minor differences in renal osteodystrophy features between wild-type and sclerostin knockout mice with chronic kidney disease
    Cejka, Daniel
    Parada-Rodriguez, Diego
    Pichler, Stefanie
    Marculescu, Rodrig
    Kramer, Ina
    Kneissel, Michaela
    Gross, Thomas
    Reisinger, Andreas
    Pahr, Dieter
    Monier-Faugere, Marie-Claude
    Haas, Martin
    Malluche, Hartmut H.
    KIDNEY INTERNATIONAL, 2016, 90 (04) : 828 - 834
  • [46] Proteinuria-associated renal magnesium wasting leads to hypomagnesemia: a common electrolyte abnormality in chronic kidney disease
    Oka, Tatsufumi
    Hamano, Takayuki
    Sakaguchi, Yusuke
    Yamaguchi, Satoshi
    Kubota, Keiichi
    Senda, Masamitsu
    Yonemoto, Sayoko
    Shimada, Karin
    Matsumoto, Ayumi
    Hashimoto, Nobuhiro
    Mori, Daisuke
    Monden, Chikako
    Takahashi, Atsushi
    Obi, Yoshitsugu
    Yamamoto, Ryohei
    Takabatake, Yoshitsugu
    Kaimori, Jun-Ya
    Moriyama, Toshiki
    Horio, Masaru
    Matsui, Isao
    Isaka, Yoshitaka
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (07) : 1154 - 1162
  • [47] Association between the urinary sodium-to-potassium ratio and renal outcomes in patients with chronic kidney disease: a prospective cohort study
    Matsukuma, Yuta
    Nakayama, Masaru
    Tsuda, Susumu
    Fukui, Akiko
    Yoshitomi, Ryota
    Tsuruya, Kazuhiko
    Nakano, Toshiaki
    Kitazono, Takanari
    HYPERTENSION RESEARCH, 2021, 44 (11) : 1492 - 1504
  • [48] Association of kidney disease measures with risk of renal function worsening in patients with hypertension and type 2 diabetes
    Viazzi, Francesca
    Piscitelli, Pamela
    Giorda, Carlo
    Ceriello, Antonio
    Genovese, Stefano
    Russo, Giuseppina T.
    Fioretto, Paola
    Guida, Pietro
    De Cosmo, Salvatore
    Pontremoli, Roberto
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2017, 31 (02) : 419 - 426
  • [49] Efficacy and renal outcomes of SGLT2 inhibitors in patients with type 2 diabetes and chronic kidney disease
    Kelly, Michael S.
    Lewis, Jelena
    Huntsberry, Ashley M.
    Dea, Lauren
    Portillo, Ivan
    POSTGRADUATE MEDICINE, 2019, 131 (01) : 31 - 42
  • [50] Renal outcomes and prognostic factors in patients with type-2 diabetes and chronic kidney disease confirmed by renal biopsy
    Jing, Na
    Pan, Mengxing
    Song, Yi
    Guo, Feng
    Zhang, Haohao
    Wang, Jiao
    Cao, Zhe
    Liu, Shiyu
    Wu, Lina
    Ji, Hongfei
    Huang, Fengjuan
    Ding, Xiaoxu
    Qi, Chang
    Huang, Sen
    Yang, Xinyu
    Zhang, Li
    Song, Chunhua
    Qin, Guijun
    Zhao, Yanyan
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2021, 12